Codexis featured in CBS News’ Economy 4.0

Codexis is proud to be featured in CBS News’ Economy 4.0, a docuseries that explores how advanced technologies are shaping the future of global industries. This segment highlights Codexis’s role in the fourth industrial revolution—where biotechnology, automation, and sustainability converge to solve some of the most pressing challenges in healthcare.

Why Economy 4.0 matters

Economy 4.0 represents a new era of innovation, where data-driven processes, AI, and advanced manufacturing are transforming how products are developed and delivered. For the pharmaceutical industry, this means accelerating the journey from discovery to patient care—while reducing environmental impact and improving scalability.

Transforming RNA therapeutics

RNA-based medicines are redefining how we treat disease—delivering precision therapies for conditions ranging from rare genetic disorders to widespread chronic illnesses like diabetes, cardiovascular disease, and cancer. Yet as the promise of RNA therapeutics grows, so does the challenge of producing them at scale, efficiently, and sustainably.

Codexis is addressing this challenge with its ECO Synthesis Manufacturing Platform—an enzymatic process that revolutionizes RNA production. By leveraging enzymatic synthesis, ECO Synthesis delivers:

• High-fidelity synthesis with minimal waste
• Greater scalability for commercial manufacturing
• Cleaner, more sustainable processes that replace traditional phosphoramidite chemistry

This innovation supports the pharmaceutical industry’s transition toward agile, eco-friendly manufacturing—critical for meeting global health needs.

With more than two decades of expertise in enzyme engineering, Codexis is uniquely positioned to transform RNA therapeutics manufacturing. The company’s participation in Economy 4.0 underscores its commitment to:

• Innovation – Applying cutting-edge science and technology to overcome manufacturing bottlenecks.
• Sustainability – Reducing waste and environmental impact in therapeutic production.
• Accessibility – Helping ensure life-changing medicines reach patients faster and more efficiently.

Stephen Dilly, Executive Chairman, explains:
“We’re honored to be part of Economy 4.0 and to share how the ECO Synthesis Manufacturing Platform is helping reshape RNA manufacturing for a healthier, more accessible future.”